Stay updated on Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, signaling a new release, and the 'Back to Top' element has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T18:52:50.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-07T13:38:18.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations across Brazil, China, and South Korea, while also removing previous location entries and related terms. Notably, the drug upadacitinib has been reintroduced in the context of drug safety and counterfeit drugs.
    Difference
    5%
    Check dated 2025-08-31T11:34:13.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T00:57:25.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T20:09:23.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The webpage has added significant content regarding a clinical study involving Upadacitinib for rheumatoid arthritis, including detailed study objectives, eligibility criteria, and locations for participation. Additionally, it now includes a disclaimer about the U.S. government's review of studies listed on the site.
    Difference
    100%
    Check dated 2025-08-02T15:22:08.000Z thumbnail image

Stay in the know with updates to Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.